# A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts

> **NCT00130325** · NA · COMPLETED · sponsor: **Medical Research Council Unit, The Gambia** · enrollment: 214 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Isoniazid
- **DRUG:** Isoniazid
- **DRUG:** Placebo of Isoniazid tablets 300mg

## Key facts

- **NCT ID:** NCT00130325
- **Lead sponsor:** Medical Research Council Unit, The Gambia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-10
- **Final completion:** 2009-06
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2010-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130325, "A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00130325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*